Scheffler, M., Gardizi, M., Nogova, L., Michels, S., Woempner, C., Persigehl, T. and Wolf, J. (2014). BARIS: A phase I trial to evaluate the safety and tolerability of combined nintedanib and everolimus in solid tumors and to determine the maximum tolerated dose (MTD) of the combination. Oncol. Res. Treat., 37. S. 155 - 156. BASEL: KARGER. ISSN 2296-5262

Full text not available from this repository.

Item Type: Journal Article
Creators:
CreatorsEmailORCIDORCID Put Code
Scheffler, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Gardizi, M.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Nogova, L.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Michels, S.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Woempner, C.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Persigehl, T.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
Wolf, J.UNSPECIFIEDUNSPECIFIEDUNSPECIFIED
URN: urn:nbn:de:hbz:38-426870
Journal or Publication Title: Oncol. Res. Treat.
Volume: 37
Page Range: S. 155 - 156
Date: 2014
Publisher: KARGER
Place of Publication: BASEL
ISSN: 2296-5262
Language: English
Faculty: Unspecified
Divisions: Unspecified
Subjects: no entry
Uncontrolled Keywords:
KeywordsLanguage
OncologyMultiple languages
URI: http://kups.ub.uni-koeln.de/id/eprint/42687

Downloads

Downloads per month over past year

Export

Actions (login required)

View Item View Item